7,428 Shares in Globe Life Inc. $GL Bought by Inspire Investing LLC

Inspire Investing LLC purchased a new stake in shares of Globe Life Inc. (NYSE:GL) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 7,428 shares of the company’s stock, valued at approximately $1,062,000.

A number of other large investors have also added to or reduced their stakes in GL. AdvisorNet Financial Inc raised its stake in shares of Globe Life by 60.0% during the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after acquiring an additional 84 shares during the last quarter. Intech Investment Management LLC raised its position in Globe Life by 0.8% during the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after purchasing an additional 95 shares during the last quarter. Creative Planning lifted its holdings in Globe Life by 0.3% in the 2nd quarter. Creative Planning now owns 36,855 shares of the company’s stock worth $4,581,000 after buying an additional 101 shares during the period. Geneos Wealth Management Inc. lifted its holdings in Globe Life by 3.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 3,717 shares of the company’s stock worth $490,000 after buying an additional 113 shares during the period. Finally, World Investment Advisors grew its position in shares of Globe Life by 3.7% in the 3rd quarter. World Investment Advisors now owns 3,189 shares of the company’s stock worth $456,000 after buying an additional 114 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling at Globe Life

In other news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares in the company, valued at approximately $5,036,943.24. This trade represents a 20.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.51% of the company’s stock.

Globe Life Price Performance

GL opened at $143.50 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41. The company has a market cap of $11.42 billion, a price-to-earnings ratio of 10.40 and a beta of 0.48. The stock has a fifty day simple moving average of $134.73 and a two-hundred day simple moving average of $133.69. Globe Life Inc. has a 12-month low of $107.25 and a 12-month high of $147.83.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, topping analysts’ consensus estimates of $4.54 by $0.27. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.52 billion. Globe Life had a net margin of 19.36% and a return on equity of 21.81%. During the same period in the prior year, the firm earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS and its FY 2025 guidance at 14.400-14.600 EPS. Research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Monday, January 5th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, January 5th. Globe Life’s dividend payout ratio is 7.83%.

Analysts Set New Price Targets

GL has been the subject of a number of recent analyst reports. Morgan Stanley restated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Wells Fargo & Company reduced their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday. Keefe, Bruyette & Woods lifted their target price on shares of Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Finally, Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $164.89.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.